AW
SUPN icon

Avion Wealth’s Supernus Pharmaceuticals SUPN Stock Holding History

Avion Wealth’s Portfolio SUPN Stock Details SUPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2K Hold
43
– – ﹤0.01% 920
2025
Q4 		$2K Hold
43
– – ﹤0.01% 928
2025
Q3 		$2K Hold
43
– – ﹤0.01% 912
2025
Q2 		$1K Hold
43
– – ﹤0.01% 1072
2025
Q1 		$1K Hold
43
– – ﹤0.01% 932
2024
Q4 		$1K Hold
43
– – ﹤0.01% 930
2024
Q3 		$1K Hold
43
– – ﹤0.01% 909
2024
Q2 		$1K Hold
43
– – ﹤0.01% 818
2024
Q1 		$2K Hold
43
– – ﹤0.01% 774
2023
Q4 		$1K Buy
+43
New +$1.14K ﹤0.01% 972

Other funds holding SUPN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Avion Wealth's SUPN Position: Q1 2026 in Review

Avion Wealth held its Supernus Pharmaceuticals (SUPN) position steady in Q1 2026 at 43 shares worth $2K. The position accounts for ﹤0.01% of the portfolio, ranked #920.

Avion Wealth first reported a position in SUPN in Q4 2023 and has held it in 10 quarters since. 327 funds tracked by Wall St. Rank hold SUPN as of Q1 2026.

  • Avion Wealth held 43 shares of Supernus Pharmaceuticals worth $2K as of Q1 2026.
  • Avion Wealth left its Supernus Pharmaceuticals share count unchanged in Q1 2026.
  • Supernus Pharmaceuticals made up ﹤0.01% of Avion Wealth's portfolio in Q1 2026, its #920 holding.
  • Avion Wealth first reported a position in Supernus Pharmaceuticals in Q4 2023 and has held it in 10 quarters since.
  • 327 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q1 2026.

Based on Avion Wealth's 13F filing for Q1 2026, filed 1 May 2026.